How many institutions own COEP stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own COEP shares is 10, representing 3.03% of the company's common stock.

Who are the major shareholders selling Coeptis Therapeutics Holdings, Inc. stock?

BARCLAYS PLC, in the last quarter, reduced its stake in COEP by -100% restricting it's holding to 0 shares of worth nearly -. UBS GROUP AG also lessened -100% of the COEP shares from its portfolio, reducing its holding to 0 shares of worth -. CITADEL ADVISORS LLC also shunned COEP shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying COEP stock?

As per its latest 13F filing, ANCHOR INVESTMENT MANAGEMENT, LLC increased its stake in COEP by 100% in the last quarter. The institutional holder raised its holding to 7 thousand shares having worth more than $122.22K. N/A also added N/A more shares of COEP to its portfolio, raising its holding to - shares of worth -. N/A also increased its COEP shares holding by N/A which brought its holding to - shares worth -.

COEP's major insiders: who are they?

The insider with the most stakes in COEP is Mehalick David , CEO and President at the company. Additionally, COEP stock is highly held by director Calise Chris and VP of Operations Yerace Daniel Alexander among others.

Did an insider recently sell COEP stock?

Company executives, directors, and other insiders own 13.49% percent of Coeptis Therapeutics Holdings, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which COEP insiders have sold stock, totaling 0 shares. Insiders that have sold shares include FORTMILLER FREDERICK VINCENT JR., MEHALICK DAVID, and GLAZER CAPITAL, LLC.

Which insider recently purchased COEP stock?

There have been 0 transaction(s) during the past 6-months in which Coeptis Therapeutics Holdings, Inc. insiders have bought stock, totalling 0 shares

How much of COEP does insiders own?

Around 0 Coeptis Therapeutics Holdings, Inc. shares are held by insiders, which represents about 13.49% of COEP stock.

Who is the insider with the largest stake?

COEP CEO and President, Mehalick David holds the largest portfolio of the company's shares. COEP shares owned by Mehalick total nearly 2.77 million.

Which institution holds the most shares in COEP?

ANCHOR INVESTMENT MANAGEMENT, LLC is the largest institutional owner in COEP which holds 7 thousand shares worth $78.54K or 0.01% of the total COEP shares outstanding followed by ANCHOR INVESTMENT MANAGEMENT, LLC with ownership of 7 thousand shares representing 0.15% of the COEP ownership. BARCLAYS PLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is Coeptis Therapeutics Holdings, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the COEP is concerned, it is a stock which is not optionable.

Is there a short position on COEP's shares?

Number of COEP shares short is 63.65K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding COEP shares are there?

As of today, 4.82M shares of COEP are outstanding.

Is there many float in COEP stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, COEP has 4.20M shares in float.

COEP short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for COEP is 1.36.

Coeptis Therapeutics (COEP) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares1.32

Short Percent Of Float1.49

Shares Outstanding4.82M

Shares Float4.20M

Shares Short63.65K

Short Ratio1.36

1.49%

Short % of Float

1.32%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

13.49% Percentage of Shares held by All Insiders

3.03% Percentage of Shares held by All Institutions

3.51% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 3.03% of COEP shares are held by financial institutions. ANCHOR INVESTMENT MANAGEMENT, LLC is the top corporate investor, holding 7K shares valued at $78.54K. A 0.01% stake in Coeptis Therapeutics Holdings, Inc. is owned by the company. ANCHOR INVESTMENT MANAGEMENT, LLC owns 7K shares valued at $99.75K, which translates its holding of 0.15% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	ANCHOR INVESTMENT MANAGEMENT, LLC	0.01%	7K	78.54K	0	0
Dec 31, 2025	ANCHOR INVESTMENT MANAGEMENT, LLC	0.15%	7K	99.75K	0	0
Dec 31, 2025	BARCLAYS PLC	0%	0	-	-67	-100.00%
Sep 30, 2025	ANCHOR INVESTMENT MANAGEMENT, LLC	0.19%	7K	122.22K	7K	+100.00%
Dec 31, 2024	UBS GROUP AG	0%	0	-	-38.98K	-100.00%
Dec 31, 2024	CITADEL ADVISORS LLC	0%	0	-	-111.34K	-100.00%
Dec 31, 2024	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-9.57K	-100.00%
Dec 31, 2024	CREATIVE PLANNING	0%	0	-	-645.1K	-100.00%
Dec 31, 2024	GEODE CAPITAL MANAGEMENT, LLC	0%	0	-	-153.78K	-100.00%
Dec 31, 2024	MINT TOWER CAPITAL MANAGEMENT B.V.	0.01%	2.25K	12K	-42.75K	-95.00%
Dec 31, 2024	JANE STREET GROUP, LLC	0%	0	-	-31.57K	-100.00%
Dec 31, 2024	STEWARD PARTNERS INVESTMENT ADVISORY, LLC	0%	0	-	-20K	-100.00%
Dec 31, 2024	SEMMAX FINANCIAL ADVISORS INC.	0%	0	-	-112	-100.00%
Dec 31, 2024	METEORA CAPITAL, LLC	0%	0	-	-446.25K	-100.00%
Dec 31, 2024	ARISTA WEALTH MANAGEMENT, LLC	0%	0	-	-47.33K	-100.00%
Dec 31, 2024	BANK OF AMERICA CORP /DE/	0%	0	-	-201	-100.00%
Dec 31, 2024	VANGUARD GROUP INC	0%	0	-	-100.76K	-100.00%
Dec 31, 2024	CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	0%	0	-	-56.15K	-100.00%

Insiders

Among the COEP insiders holding of 13.49% of the stake in company, MEHALICK DAVID, CEO and President, holds the largest shares of 2.77M. CALISE CHRIS, director, is the second largest COEP insider with ownership of 1.46M shares. YERACE DANIEL ALEXANDER, VP of Operations, stands third with possession of 1.07M shares of that stake.

Insiders	Designation	Shares Held
MEHALICK DAVID	CEO and President	2.77M
CALISE CHRIS	director	1.46M
YERACE DANIEL ALEXANDER	VP of Operations	1.07M
GLAZER CAPITAL, LLC	10 percent owner	964.42K
FORTMILLER FREDERICK VINCENT JR.		429.13K
SALKIND GENE	director	284.06K
COCHRAN CHRISTOPHER P.	director	37K
DESILVA TARA	director	30.47K
COGLEY BRIAN	Chief Financial Officer	30K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jan 12, 2024	DESILVA TARA	PURCHASE	0.56	466	260.96	30.47K
Jan 10, 2024	COGLEY BRIAN	PURCHASE	0.67	5K	3.35K	30K
Jan 08, 2024	MEHALICK DAVID	PURCHASE	0.67	6K	4.02K	2.77M
Jan 05, 2024	COCHRAN CHRISTOPHER P.	PURCHASE	0.77	7K	5.39K	37K
Jan 05, 2024	YERACE DANIEL ALEXANDER	PURCHASE	0.69	10.85K	7.49K	1.07M
Jan 05, 2024	SALKIND GENE	PURCHASE	0.69	11.6K	8K	284.06K
Jan 05, 2024	MEHALICK DAVID	PURCHASE	0.69	5.05K	3.48K	2.76M
Aug 29, 2023	SALKIND GENE	PURCHASE	1.01	4.01K	4.05K	4.05K
Aug 25, 2023	SALKIND GENE	PURCHASE	0.91	28.64K	26.06K	28.64K
Aug 23, 2023	CALISE CHRIS	PURCHASE	0.94	9K	8.46K	1.46M
May 04, 2022	FORTMILLER FREDERICK VINCENT JR.	SALE	10.11	85.31K	862.43K	429.13K
Nov 16, 2021	MEHALICK DAVID	SALE	0.00	1.2M	-	1.8M
May 26, 2021	GLAZER CAPITAL, LLC	SALE	9.85	6.12K	60.26K	964.42K
May 25, 2021	GLAZER CAPITAL, LLC	SALE	9.85	50K	492.5K	1.02M

COEP Stock Ownership Breakdown